2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

🏆 Top 10📊 OpenAlex

#5PRI RANKED

Most Cited Paper

in Heart Failure Treatment and Management

18 Months Post-Publication

Class of 2026

“2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure”

AuthorsAuthors/Task Force Members: et al.

Theresa A. McDonagh, Marco Metra

JournalEuropean Journal of Heart Failure

United Kingdom.

Citations222

DOI10.1002/ejhf.3024

A research intelligence initiative by Pepkio

pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026/

Topics

Acute decompensated heart failure · chronic heart failure · Heart failure with reduced ejection fraction · Heart failure with mildly reduced ejection fraction · Heart failure with preserved ejection fraction · SGLT2 inhibitors · SGLT2 inhibitors · Guideline-Directed Medical Therapy · Iron deficiency · Iron supplementation · Anemia · Type 2 diabetes · Cardiovascular risk reduction · Diuretic Therapy · Renin-angiotensin system inhibition · Beta-blockers · Mineralocorticoid receptor antagonists · Cardiac resynchronization therapy · Heart failure hospitalization · Cardiovascular death · Clinical practice guidelines · evidence-based medicine · Heart failure management · Comorbidity Management · Left ventricular ejection fraction · Natriuretic peptides · Ferric carboxymaltose · Chronic Kidney Disease · Randomized controlled trial · Risk stratification

Share on X

Cite this ranking

Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-07-13.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459